What Analysts Recommend for Novartis Stock
In Q2 2018, analysts expect Novartis’s revenue to fall 7.6% YoY (year-over-year) to $13.2 billion from $12.2 billion. They expect Novartis to see EPS of $1.32, and its net income margin to decrease YoY to 22.8% from 23.3%, mainly due to higher SG&A (selling, general, and administrative) and R&D (research and development) expenses.